WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

1. Introduction

As a requirement, under Article 5.4.1 of the 2021 World Anti-Doping Code (Code); “Anti-Doping
Organizations shall conduct test distribution planning and Testing as required by the International
Standard for Testing and Investigations.” The International Standard for Testing and Investigations
(ISTI) outlines in Article 4.2.4. that: “In developing its Test Distribution Plan, the Anti-Doping
Organization shall incorporate the requirements of the TDSSA.”

This Technical Document for Sport Specific Analysis (TDSSA) is intended to ensure that the
Prohibited Substances and/or Prohibited Methods within the scope of the TDSSA and other tools
that support the detection of Prohibited Substances and/or identify the Use of Prohibited Methods
such as the Athlete Biological Passport (ABP) are subject to an appropriate and consistent level of
use, analysis and adoption by all Anti-Doping Organizations (ADOs) that conduct Testing in those
sports or disciplines deemed at risk. Compliance with the TDSSA is mandatory under the Code.

The TDSSA complements other anti-doping tools and programs such as the ABP, intelligence
gathering and investigations. The development of the TDSSA is based on a scientific approach,
linking physiological and non-physiological demand of Athlete performance with the potential
ergogenic benefit of those Prohibited Substances and/or Prohibited Methods within the scope of the
TDSSA.

A Minimum Level of Analysis (MLA) is specified for the Prohibited Substances and/or Prohibited
Methods within the scope of the TDSSA for each sport or discipline, expressed as a percentage of
the total number of eligible Tests and based on a Physiological Risk Assessment of that sport or
discipline. The full MLA list for each sport or discipline is provided in Appendices 1 and 2 of this
Technical Document which are also a mandatory component of the TDSSA.

The MLA applies to Testing conducted by all ADOs on International-Level Athletes and National-
Level Athletes as defined by the applicable ADO.

The MLAs for each sport or discipline should not be considered as the precise level of analysis that
an ADO should implement in that sport or discipline. ADOs are encouraged to exceed the MLAs
where they believe it is appropriate to do so, based on their Risk Assessment and any intelligence
information they may have access to. ADOs are also encouraged to take advantage of Article 6.6 of
the Code, which permits ADOs to request Laboratories to analyze Samples that have already been
reported as negative and have been stored for Further Analysis, for the Prohibited Substances and/or
Prohibited Methods within the scope of the TDSSA.

The full Prohibited List remains applicable to all sports, including sports that are not covered by the
TDSSA and/or for which the MLA is zero (0%). Any ADO may, at its own discretion, request a
Laboratory to analyze any Sample for the Prohibited Substances and/or Prohibited Methods within
the scope of the TDSSA at any time.

In addition, under Article 6.4.1 of the Code, “Laboratories at their own initiative and expense may
analyze Samples for Prohibited Substances and/or Prohibited Methods not included on the standard
Sample analysis menu or as requested by the Anti-Doping Organization that initiated and directed

TDSSA - Version 6.0, dated 11 November 2020 Page 1 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

Sample collection.” This includes those Prohibited Substances and/or Prohibited Methods which are
described in the TDSSA.

WADA has developed a non-mandatory supporting document intended to assist with the
implementation and application of the TDSSA. This document is included herein as Supporting
Document A but is not to be considered an appendix of the TDSSA itself, as it will be amended from
time to time to reflect the ongoing needs of stakeholders and evolving best practice.

Defined terms in the Code, International Standards and the TDSSA can be found in Article 10 of the
TDSSA.

2. Objectives

The objectives of the TDSSA are to contribute to effective Testing by:

2.1. Maintaining well-reasoned and proportionate MLAs for those Prohibited Substances and/or
Prohibited Methods within the scope of the TDSSA in particular sports or disciplines;

2.2. Establishing criteria by which all ADOs shall apply MLAs within a Test Distribution Plan (TDP)
while recognizing the need for flexibility within the diversity of Code-compliant anti-doping
programs;

2.3. Ensuring the TDSSA supports the implementation of the haematological module of the ABP
to continue to allow for intelligent Testing and targeted analysis for Erythropoietin-Receptor
Agonists (ERAs, named for the purposes of this Technical Document EPOs1); and

2.4. Informing ADOs on Testing and analysis best practices for those Prohibited Substances
and/or Prohibited Methods within the scope of the TDSSA in particular sports or disciplines.

3. Scope

3.1. Level of Athlete

The TDSSA applies to Testing conducted on International-Level Athletes and National-Level

Athletes (as defined by International Federations (IFs) and National Anti-Doping
Organizations (NADOs), respectively). ADOs may also apply the TDSSA to Recreational or
other Athletes within their jurisdiction. Only analyses conducted on International-Level
Athletes and National-Level Athletes will be used to determine whether the applicable MLAs
have been met and compliance with the TDSSA. For the purpose of the TDSSA, all Athletes

1
The acronym ‘EPOs’ is used in this Technical Document to describe the substances included under the category
S.2.1.1 of the 2021 Prohibited List and analyzed according to the applicable WADA Technical Document for EPO
in force.

TDSSA - Version 6.0, dated 11 November 2020 Page 2 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

competing in Events which are under the jurisdiction of a Major Event Organization (MEO)
will be presumed to be International-Level Athletes or National-Level Athletes.

3.2. Prohibited Substances and/or Prohibited Methods2 included within the TDSSA

The Prohibited Substances and/or Prohibited Methods within the scope of the TDSSA are
normally not part of a standard Sample analysis conducted by Laboratories and require
additional analysis methods.

The Prohibited Substances and/or Prohibited Methods within the current scope of the TDSSA
are:

• Erythropoietin-Receptor agonists (EPOs) as listed in Section S2.1.1;

• Growth Hormone (GH) as listed in Section S2.2.3; and
• Growth Hormone Releasing Factors (GHRFs) including Growth Hormone Releasing
Hormone (GHRH) and its analogues, Growth Hormone Secretagogues (GHS) and
Growth Hormone Releasing Peptides (GHRPs) as listed in Section S2.2.3.

Whilst implementation of the GHRFs MLAs has been mandatory since 1 January 2017, the
mandatory implementation of the GH MLAs for all sports or disciplines has been postponed
until the endocrine module of the ABP is ready for implementation.

During the period of the GH MLAs postponement:

• ADOs are encouraged to continue their best efforts to conduct GH Testing by prioritizing
the higher risk sports or disciplines listed in the TDSSA;
• In situations where Samples are reported as an Atypical Finding for GH, and/or where
investigations indicate reliable intelligence on possible GH abuse, ADOs should target
the Athlete for GH analysis. In addition, ADOs are strongly encouraged to request long-
term storage for such Samples for Further Analysis when further technological
advancements for GH analysis are available; and
• ADOs will not be held accountable under WADA’s compliance monitoring program for
any failure to meet the relevant GH MLAs.

Information about the Prohibited Substances and/or Prohibited Methods within the scope of
the TDSSA and guidance on Testing strategies for each Prohibited Substance is provided
within the TDSSA Testing Guides3.

2
Contained within the 2021 WADA Prohibited List.
3
Please contact [email protected] for a copy of the TDSSA Testing Guides.

TDSSA - Version 6.0, dated 11 November 2020 Page 3 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

3.3. Implementation of the haematological module of the ABP

The haematological module of the ABP plays an important part in the targeting of Athletes for
Testing, the detection of EPOs and prosecution of anti-doping rule violations for Use of blood
doping methods. The implementation of the haematological module of the ABP for sports or
disciplines with an EPOs MLA of 30% or greater has been a mandatory component of
compliance with the TDSSA since 1 January 2019.

In addition, the implementation of the haematological module of the ABP shall include the
following mandatory criteria:

a) Include all Athletes from those sports or disciplines with an EPOs MLA of 30% or greater
(as identified in the TDSSA) that are referenced in an ADO’s TDP, and are part of the
ADO’s Registered Testing Pool (RTP);

b) The program shall be compliant with all applicable ABP Technical Documents and
International Standards, including the ISTI, the International Standard for Results
Management and the applicable Technical Document for Athlete Passport Management
Units (APMU) in force;

c) At a minimum, an average of three blood ABP Tests shall be planned annually across all
Athletes from those sports or disciplines with an EPOs MLA of 30% or greater, who are
part of the RTP of an ADO and therefore part of the ADO’s ABP haematological module
program; and

d) The distribution of these Tests shall be carried out according to the status of the Athlete’s
Passport, as well as any intelligence the ADO may have access to and the
recommendations of the APMU, so that Athletes with atypical/suspicious Passports
receive more Tests than those with normal Passports.

ADOs will be required to report the details of their RTP to WADA through the Anti-Doping
Administration and Management System (ADAMS). An ADO’s compliance in relation to its
haematological ABP program will be monitored by WADA as part of its wider compliance
monitoring program based on the criteria outlined above and as per the ISTI.

As a guide to WADA’s assessment of the required number of blood ABP Tests per ADO (see
criterion c) above), the annual number of blood ABP Tests conducted by the ADO and
recorded in ADAMS will be divided by the number of Athletes in the RTP from the sports or
disciplines with an EPOs MLA of 30% or greater. As an example, if a NADO has 100 Athletes
in its RTP, of which 25 are from sports or disciplines with an EPOs MLA of 30% or greater,
then the ADO shall focus on these 25 Athletes from sports or disciplines with an EPOs MLA

TDSSA - Version 6.0, dated 11 November 2020 Page 4 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

of 30% or greater and plan to conduct a minimum of 75 blood ABP Tests (an average of three
Tests x 25 RTP Athletes) during the course of that year.

RTP Athletes with atypical or suspicious Passports, as identified by the APMU, should be
subject to greater than three blood ABP Tests during the course of the year. RTP Athletes
with normal Passports should have at least one blood ABP Test during the course of the year.
For an RTP Athlete from a sport or discipline with an EPOs MLA of 30% or greater with no
previous blood ABP Tests, the ADO shall plan to conduct a minimum of three blood ABP Tests
within the first year to establish a baseline and then adjust the Testing frequency, in
consultation with the ADO’s APMU and intelligence to which the ADO may have access.

These requirements do not prevent the implementation by an ADO of the ABP haematological
module on Athletes outside of its RTP or those in the RTP of another ADO.

Implementation of the haematological module of the ABP for those sports or disciplines for
which the MLA for EPOs is 15% is strongly recommended. For those sports or disciplines
with an MLA for EPOs of 10%, ADOs are encouraged to consider the benefits of implementing
the haematological module of the ABP. When implementing the haematological module of the
ABP for sports or disciplines with an EPOs MLA of 15% or less, ADOs are encouraged to
apply the same criteria as outlined in b) to d) above.

Implementation of the haematological module of the ABP also enables ADOs to seek a
reduction in the MLA percentage for EPOs, subject to meeting the criteria outlined in Article 6
of the TDSSA.

4. MLA for Sports and Disciplines

MLAs for sports and disciplines are located in:

• Appendix 1 – Minimum Levels of Analysis for Sports and Disciplines of Olympic, IOC
Recognized and Non-Recognized International Federations4
• Appendix 2 – Minimum Levels of Analysis for Sports and Disciplines for Athletes with an
Impairment

4
Includes only those non-International Olympic Committee (IOC) recognized sports that are members of the Alliance of Independent Recognized
Members of Sport (AIMS).

TDSSA - Version 6.0, dated 11 November 2020 Page 5 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

5. Test Distribution Planning and MLA Percentages

5.1. Test Distribution Plan

In accordance with Article 4.1.1 of the ISTI, each ADO is required to plan and implement
intelligent Testing on Athletes over whom it has authority which is proportionate to the risk of
doping, and that is effective to detect and to deter such practices.

The TDSSA is part of the Risk Assessment and the overall TDP development process. Once
a TDP is developed, each ADO will be responsible for managing the implementation of the
TDSSA throughout their Testing year by applying the required MLAs in a targeted manner to
defined Athletes.

5.2. Applying MLAs to the Test Distribution Plan

The aim is to test the right Athletes for the right Prohibited Substance(s) and/or Prohibited
Methods at the right time. Once an ADO has conducted the required Risk Assessment and
assigned Tests to a sport or discipline within its TDP, it shall apply the prescribed MLA
percentage to the number of Tests allocated to each sport or discipline to determine the
minimum number of analyses required for each Prohibited Substance.

For the purposes of this calculation, one Test includes any number of Samples that are
collected from one Athlete during a single Sample Collection Session. For example, a Sample
Collection Session in which one urine Sample and two blood Samples are collected will count
as one Test. Blood ABP Tests, conducted in isolation, shall not be included in this calculation.

As a further example in applying the MLA to a TDP, if an ADO’s TDP for a sport or discipline
consists of 100 Tests and its MLAs are 60% for EPOs, 10% for GH and 10% for GHRFs, then
the minimum number of analyses an ADO should conduct is as follows:

- 60 EPOs analyses to be conducted in either urine or blood;

- 10 GH analyses in blood (serum); and

- 10 GHRFs analyses in urine

ADOs can request multiple analyses on Samples collected during the same Sample Collection
Session. In the example above, the absolute minimum number of Sample Collection Sessions
could be 60. This is on the basis that the required number of GH and GHRF analyses is
performed on those Athletes who are also being tested for EPOs.

TDSSA - Version 6.0, dated 11 November 2020 Page 6 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

The remaining 40 Tests from the 100 Tests would then be subject to either the standard
routine urine analysis or a greater level of TDSSA or other analysis, which ADOs are
encouraged to do.

Any MLA that does not equal a whole number when applied to total Tests shall be rounded
up or down to the nearest whole number. For example, if five Tests are planned in a particular
sport or discipline, for which the EPOs MLA is 10%, the ADO will be required to conduct a
minimum of one EPOs analysis (i.e. 5 × 10% = 0.5, which is rounded up to 1). Respectively,
if four Tests are planned in a particular sport or discipline, for which the GHRFs MLA is 10%,
the ADO will not be required to conduct any GHRFs analysis (i.e. 4 × 10% = 0.4, which is
rounded down to 0).

Where the ADO has intelligence that would lead to a more effective use of one analysis
allocated to a sport or discipline on an Athlete in a sport or discipline of higher risk, the ADO
may reallocate that single analysis.

Although compliance with the TDSSA requirements is mandatory, the total number of athletes
eligible for testing, the selection of the Athletes to be tested, the selection of the Sample
matrices collected (i.e. urine or blood) and the timing of those Tests and types of analyses
applied to collected Samples remain at the discretion of the ADO.

Achieving the MLAs for the applicable sports or disciplines should be based on quality of
Testing, and not simply reaching a required number of Tests. Thus, allocations of Tests should
be based on intelligence where possible and may include ABP information, whereabouts,
timing of competition periods, and any other information that may affect the pattern and the
timing of Use of the Prohibited Substances and/or Prohibited Methods within the scope of the
TDSSA.

Further guidance on the implementation of the TDSSA within a TDP can be found in the
WADA “Guidelines for Implementing an Effective Testing Program”, the TDSSA Testing
Guides and the Frequently Asked Questions (FAQs) located in Supporting Document A.

5.3. Sports and Disciplines with MLAs of five percent (5%)

To increase flexibility and to enable ADOs to focus resources on higher risk sports or
disciplines, compliance with the TDSSA requirements for sport or disciplines with an MLA of
5% is optional. However, ADOs are strongly encouraged to continue their best efforts to meet
the 5% MLAs for the respective sports or disciplines listed in the TDSSA to maintain
deterrence.

TDSSA - Version 6.0, dated 11 November 2020 Page 7 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

5.4. Sports and Disciplines with MLAs of zero percent (0%)

Those sports or disciplines that are determined to be at minimal physiological risk to the abuse
of the Prohibited Substances and/or Prohibited Methods within the scope of the TDSSA, and
for which the associated MLA is 0%, shall remain subject to In-Competition and Out-of-
Competition standard urine analysis menus.

However, such sports or disciplines may be subject to Testing at any time by any ADO for
those Prohibited Substances and/or Prohibited Methods within the scope of the TDSSA,
especially if the ADO gathers specific information relating to potential use of such Prohibited
Substances and/or Prohibited Methods.

6. Flexibility in implementing the MLAs

Article 4.7.2 of the ISTI outlines that: “An Anti-Doping Organization may apply to WADA for flexibility
in the implementation of the minimum levels of analysis specified for Prohibited Substances or
Prohibited Methods as outlined in the TDSSA.”

In order for WADA to consider flexibility in the implementation of the MLAs, the ADO shall
demonstrate its implementation of the haematological module of the ABP and/or the implementation
of intelligence-led Testing strategies and/or tools and how such approaches lead to the most
effective and efficient use of the available Testing resources. Compliance with the TDSSA alone is
not sufficient.

Following the completion of a self-assessment against set criteria, and the submission to WADA of
relevant documents such as the ADO’s Risk Assessment, TDP and RTP, an ADO will automatically
qualify for flexibility in the implementation of the MLAs of up to 50% for the sports or disciplines the
ADO seeks flexibility for, subject to a review by WADA.

WADA withholds the right to request further information from the ADO to justify the requested
flexibility. WADA may withdraw or reduce the level of flexibility if the self-assessment was incorrectly
answered or relevant documents requested are partially/not submitted within the requested timelines
or are found not to be compliant with the ISTI.

The self-assessment criteria include (but are not limited to) the following:

6.1. Implementation of the haematological module of the ABP (applies to the MLA for EPOs
only).

To be eligible for flexibility of up to 50% of the EPOs MLAs for the sports or disciplines based
on the adoption of the haematological module of the ABP, the ADO shall be able to
demonstrate that it meets all of the below:

TDSSA - Version 6.0, dated 11 November 2020 Page 8 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

6.1.1 The ABP program of the sport or discipline has been operational for at least 12 months;

6.1.2 The ABP program implements Target Testing that acts upon the recommendations of
an APMU with reference to EPOs;

6.1.3 All relevant ABP data, including Doping Control forms (DCFs), are available in
ADAMS, which permits oversight by WADA;

6.1.4 All criteria described in Article 3.3 of this Technical Document are met; and

6.1.5 The ABP program is managed by a WADA-approved Athlete Passport Management

Unit (APMU) in accordance with the applicable Technical Document for APMUs in
force.

6.2. Non-ABP (haematological module) related criteria

Flexibility in implementing the MLAs due to non-ABP related criteria may only be implemented
for the Prohibited Substances and/or Prohibited Methods within the scope of the TDSSA. Such
criteria include (but are not limited to):

a) prioritization of Target Testing for both In-Competition and Out-of-Competition;

b) collaboration with other ADOs, for example in sharing Testing plans for Athletes of joint
interest;

c) mechanisms to gather intelligence and use of such intelligence in the implementation of

an ADO’s anti-doping program, including conducting investigations;

d) collaboration with law enforcement authorities;

e) alternative Testing strategies including the application of specific analysis for other
Prohibited Substances and/or Prohibited Methods outside the scope of the TDSSA;

f) long-term storage of Samples in line with a documented storage and Further Analysis
strategy; and

g) compliant entry of DCFs into ADAMS within 21 days of Sample collection.

Upon WADA’s request, an ADO shall demonstrate that the above criteria are actively part of
the ADO’s anti-doping program.

TDSSA - Version 6.0, dated 11 November 2020 Page 9 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

6.3. Application for flexibility in the implementation of the MLAs

The process and the full list of criteria required to support an application for flexibility in
implementing the MLAs can be found in WADA’s Code Compliance Center and the
Application for Flexibility User Guide on WADA’s website.

6.4. Period for flexibility in the implementation of the MLAs

Flexibility in the implementation of the MLAs will remain valid for a maximum period of two
years provided that the ADO continues to comply with the list of criteria included in WADA’s
Code Compliance Center or the Application for Flexibility User Guide. If the ADO no longer
meets the criteria contained within its application for flexibility, the ADO shall notify WADA.

Applications for flexibility are subject to review by WADA at any time. Should an ADO wish to
extend the validity period of its flexibility, the ADO shall contact WADA in advance of its
expiration.

7. Documentation

ADOs shall ensure the following information is accurately recorded on the applicable document or
in ADAMS to ensure that WADA can monitor and evaluate an ADO’s implementation of the TDSSA:

7.1. Sport and Discipline on the DCF

To ensure accurate recording of Sample analysis by the Laboratories and reporting of

statistics in ADAMS, Testing Authorities, Sample Collection Authorities and their Doping
Control Officers must ensure that the correct sport and discipline for the Athlete, as listed in
Appendices 1 and 2 of the TDSSA, is recorded at a minimum on the Laboratory copy of the
DCF.

7.2. Type of Analysis for each Sample

The request for analysis of the Prohibited Substances and/or Prohibited Methods within the
scope of the TDSSA shall be provided to the Laboratory for each Sample to ensure the
Laboratory conducts the correct analyses and accurately reports the results in ADAMS.

The specific type of analysis required for each Sample shall be recorded on the chain of
custody (or equivalent) documentation shipped with the Samples to the Laboratory or by an
otherwise effective communication method that has been agreed with the Laboratory
responsible for analyzing an ADO’s Samples. However, the type of analysis requested shall
not be recorded on the DCF.

TDSSA - Version 6.0, dated 11 November 2020 Page 10 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

7.3. Level of Athlete being Tested

The TDSSA shall be applicable to International-Level Athletes and National-Level Athletes as

defined by each ADO. To assist with the monitoring of an ADO’s TDP and compliance with
the application of the MLAs to those defined Athletes, ADOs shall record the level of the
Athlete in ADAMS. ADOs may be requested to validate such data to WADA as part of WADA’s
wider compliance program.

8. Data Analysis and Monitoring

To monitor compliance, WADA utilizes the TDSSA Monitoring tool in ADAMS Next Gen or the
Reporting Guide to Monitor Testing. It is strongly recommended that ADOs use these tools to monitor
their compliance with the TDSSA regularly. The Reporting Guide to Monitor Testing can be found
on WADA’s website.

For TDSSA monitoring and compliance purposes, WADA will assess whether the ADO has complied
with the MLAs based on Doping Control statistics contained in ADAMS. This will include, but not be
limited to, the following elements:

• Total number of Tests and types of analyses;

• MLA achieved for each Prohibited Substance category within the scope of the TDSSA for each
sport or discipline listed in the ADO’s TDP;
• Number of Athletes tested; and
• Implementation of the haematological module of the ABP for sports or disciplines with an EPOs
MLA equal to or greater than 30%, for RTP Athletes.

These statistics and any other relevant information will also be used to review and modify the TDSSA
over time.

It is expected that ADOs will also utilize this data to assist in the review of their TDP and the
management of their Doping Control programs.

A wider evaluation of ADOs’ compliance with the TDSSA is being addressed through WADA’s
continuous compliance and monitoring program. The evaluation includes a review of the methods
applied by the ADOs to the implementation of the Tests in order to meet the MLAs as outlined in the
ISTI, including but not limited to the assessment of risk among Athletes within the jurisdiction of the
ADO, and the use of information and intelligence in the selection and timing of Tests on defined
Athletes.

As outlined in Section 6, ADOs may apply for flexibility in implementing the MLAs based on their
implementation of the haematological module of the ABP and/or use of intelligence-led Testing
strategies and other tools that will lead to the most effective and efficient use of available resources.

TDSSA - Version 6.0, dated 11 November 2020 Page 11 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

9. Review of TDSSA

As part of an ongoing review process, WADA will monitor the implementation of the TDSSA.
Revisions to the TDSSA may be issued from time to time based on consultation with ADOs and
Laboratories or the revision to the Code or International Standards or for other reasons at WADA’s
discretion (e.g. revisions to the Prohibited List or inclusion of a Prohibited Substance and/or
Prohibited Method that is not within the scope of the TDSSA). ADOs will be provided with prior notice
of such modifications taking effect.

10. Definitions

10.1. Defined terms from the 2021 Code that are used in the TDSSA

ADAMS: The Anti-Doping Administration and Management System is a Web-based database

management tool for data entry, storage, sharing, and reporting designed to assist
stakeholders and WADA in their anti-doping operations in conjunction with data protection
legislation.

Anti-Doping Organization: WADA or a Signatory that is responsible for adopting rules for
initiating, implementing or enforcing any part of the Doping Control process. This includes, for
example, the International Olympic Committee, the International Paralympic Committee, other
Major Event Organizations that conduct Testing at their Events, International Federations, and
National Anti-Doping Organizations.

Athlete: Any Person who competes in sport at the international level (as defined by each
International Federation) or the national level (as defined by each National Anti-Doping
Organization). An Anti-Doping Organization has discretion to apply anti-doping rules to an
Athlete who is neither an International-Level Athlete nor a National-Level Athlete, and thus to
bring them within the definition of “Athlete.” In relation to Athletes who are neither
International-Level nor National-Level Athletes, an Anti-Doping Organization may elect to:
conduct limited Testing or no Testing at all; analyze Samples for less than the full menu of
Prohibited Substances; require limited or no whereabouts information; or not require advance
TUEs. However, if an Article 2.1, 2.3 or 2.5 anti-doping rule violation is committed by any
Athlete over whom an Anti-Doping Organization has elected to exercise its authority to test
and who competes below the international or national level, then the Consequences set forth
in the Code must be applied. For purposes of Article 2.8 and Article 2.9 and for purposes of
anti-doping information and Education, any Person who participates in sport under the
authority of any Signatory, government, or other sports organization accepting the Code is an
Athlete.

TDSSA - Version 6.0, dated 11 November 2020 Page 12 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

[Comment: Individuals who participate in sport may fall in one of five categories: 1)
International-Level Athlete, 2) National-Level Athlete, 3) individuals who are not International
or National-Level Athletes but over whom the International Federation or National Anti-Doping
Organization has chosen to exercise authority, 4) Recreational Athlete, and 5) individuals over
whom no International Federation or National Anti-Doping Organization has, or has chosen
to, exercise authority. All International- or National-Level Athletes are subject to the anti-
doping rules of the Code, with the precise definitions of international and national level sport
to be set forth in the anti-doping rules of the International Federations and National Anti-
Doping Organizations.]

Athlete Biological Passport: The program and methods of gathering and collating data as
described in the International Standard for Testing and Investigations and International
Standard for Laboratories.

Code: The World Anti-Doping Code.

Doping Control: All steps and processes from test distribution planning through to ultimate
disposition of any appeal and the enforcement of Consequences, including all steps and
processes in between, including but not limited to, Testing, investigations, whereabouts,
TUEs, Sample collection and handling, laboratory analysis, Results Management and
investigations or proceedings relating to violations of Article 10.14 (Status During Ineligibility
or Provisional Suspension).

Event: A series of individual Competitions conducted together under one ruling body (e.g.,
the Olympic Games, World Championships of an International Federation, or Pan American
Games).

Event Period: The time between the beginning and end of an Event, as established by the
ruling body of the Event.

In-Competition: The period commencing at 11:59 p.m. on the day before a Competition in
which the Athlete is scheduled to participate through the end of such Competition and the
Sample collection process related to such Competition. Provided, however, WADA may
approve, for a particular sport, an alternative definition if an International Federation provides
a compelling justification that a different definition is necessary for its sport; upon such
approval by WADA, the alternative definition shall be followed by all Major Event
Organizations for that particular sport.

[Comment: Having a universally accepted definition for In-Competition provides greater

harmonization among Athletes across all sports, eliminates or reduces confusion among
Athletes about the relevant timeframe for In-Competition Testing, avoids inadvertent Adverse
Analytical Findings in between Competitions during an Event and assists in preventing any

TDSSA - Version 6.0, dated 11 November 2020 Page 13 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

potential performance enhancement benefits from Substances prohibited Out-of-Competition

being carried over to the Competition period.]

International-Level Athlete: Athletes who compete in sport at the international level, as

defined by each International Federation, consistent with the International Standard for
Testing and Investigations.

[Comment: Consistent with the International Standard for Testing and Investigations, the
International Federation is free to determine the criteria it will use to classify Athletes as
International-Level Athletes, e.g., by ranking, by participation in particular International
Events, by type of license, etc. However, it must publish those criteria in clear and concise
form, so that Athletes are able to ascertain quickly and easily when they will become classified
as International-Level Athletes. For example, if the criteria include participation in certain
International Events, then the International Federation must publish a list of those International
Events.]

International Standard: A standard adopted by WADA in support of the Code. Compliance

with an International Standard (as opposed to another alternative standard, practice or
procedure) shall be sufficient to conclude that the procedures addressed by the International
Standard were performed properly. International Standards shall include any Technical
Documents issued pursuant to the International Standard.

Major Event Organizations: The continental associations of National Olympic Committees

and other international multi-sport organizations that function as the ruling body for any
continental, regional or other International Event.

National Anti-Doping Organization: The entity(ies) designated by each country as

possessing the primary authority and responsibility to adopt and implement anti-doping rules,
direct the collection of Samples, manage test results and conduct Results Management at the
national level. If this designation has not been made by the competent public authority(ies),
the entity shall be the country’s National Olympic Committee or its designee.

National-Level Athlete: Athletes who compete in sport at the national level, as defined by
each National Anti-Doping Organization, consistent with the International Standard for Testing
and Investigations.

Out-of-Competition: Any period which is not In-Competition.

Prohibited List: The List identifying the Prohibited Substances and Prohibited Methods.

Prohibited Substance: Any substance, or class of substances, so described on the

Prohibited List.

TDSSA - Version 6.0, dated 11 November 2020 Page 14 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

Recreational Athlete: A natural Person who is so defined by the relevant National Anti-
Doping Organization; provided, however, the term shall not include any Person who, within
the five years (5) prior to committing any anti-doping rule violation, has been an International-
Level Athlete (as defined by each International Federation consistent with the International
Standard for Testing and Investigations) or National-Level Athlete (as defined by each
National Anti-Doping Organization consistent with the International Standard for Testing and
Investigations), has represented any country in an International Event in an open category or
has been included within any Registered Testing Pool or other whereabouts information pool
maintained by any International Federation or National Anti-Doping Organization.

[Comment: The term “open category” is meant to exclude competition that is limited to junior
or age group categories.

Regional Anti-Doping Organization: A regional entity designated by member countries to

coordinate and manage delegated areas of their national anti-doping programs, which may
include the adoption and implementation of anti-doping rules, the planning and collection of
Samples, the management of results, the review of TUEs, the conduct of hearings, and the
conduct of Educational programs at a regional level.

Registered Testing Pool: The pool of highest-priority Athletes established separately at the
international level by International Federations and at the national level by National Anti-
Doping Organizations, who are subject to focused In-Competition and Out-of-Competition
Testing as part of that International Federation's or National Anti-Doping Organization's test
distribution plan and therefore are required to provide whereabouts information as provided
in Article 5.5 and the International Standard for Testing and Investigations.

Sample or Specimen: Any biological material collected for the purposes of Doping Control.

[Comment: It has sometimes been claimed that the collection of blood Samples violates the
tenets of certain religious or cultural groups. It has been determined that there is no basis for
any such claim.]

Target Testing: Selection of specific Athletes for Testing based on criteria set forth in the
International Standard for Testing and Investigations.

Technical Document: A document adopted and published by WADA from time to time
containing mandatory technical requirements on specific anti-doping topics as set forth in an
International Standard.

Testing: The parts of the Doping Control process involving test distribution planning, Sample
collection, Sample handling, and Sample transport to the laboratory.

TDSSA - Version 6.0, dated 11 November 2020 Page 15 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

Use: The utilization, application, ingestion, injection or consumption by any means

whatsoever of any Prohibited Substance or Prohibited Method.

WADA: The World Anti-Doping Agency.

10.2. Defined Terms from the 2021 International Standards that are used in the TDSSA

Athlete Passport Management Unit (APMU): A unit composed of a Person or Persons that
is responsible for the timely management of the Athlete Biological Passports in ADAMS on
behalf of the Passport Custodian.

Doping Control Officer (or DCO): An official who has been trained and authorized by the
Sample Collection Authority to carry out the responsibilities given to DCOs in the International
Standard for Testing and Investigations.

Doping Control Station: The location where the Sample Collection Session will be
conducted in accordance with Article 6.3.2 of the International Standard for Testing and
Investigations.

Expert: The Expert(s), and/or Expert panel, with knowledge in the concerned field, chosen by
the Anti-Doping Organization and/or Athlete Passport Management Unit, who are responsible
for providing an evaluation of the Passport. The Expert must be external to the Anti-Doping
Organization.

For the Haematological Module, the Expert Panel should consist of at least three (3) Experts
who have qualifications in one or more of the fields of clinical and laboratory haematology,
sports medicine or exercise physiology, as they apply to blood doping. For the Steroidal
Module, the Expert Panel should be composed of at least three (3) individuals with
qualifications in the fields of laboratory steroid analysis, steroid doping and metabolism and/or
clinical endocrinology. For both modules, an Expert Panel should consist of Experts with
complementary knowledge such that all relevant fields are represented. The Expert Panel
may include a pool of at least three (3) appointed Experts and any additional ad hoc Expert(s)
who may be required upon request of any of the appointed Experts or by the Athlete Passport
Management Unit of the Anti-Doping Organization.

Further Analysis: Further Analysis, as this term is used in the ISL, occurs when a Laboratory
conducts additional analysis on an “A” Sample or a “B” Sample after an analytical result for
that “A” Sample or that “B” Sample has been reported by the Laboratory.

[Comment: There is no limitation on a Laboratory’s authority to conduct repeat or confirmation

analysis, or to analyze a Sample with additional Analytical Methods, or to perform any other
type of additional analysis on an “A” Sample or “B” Sample prior to reporting an analytical

TDSSA - Version 6.0, dated 11 November 2020 Page 16 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

result on that Sample. That is not considered Further Analysis. If a Laboratory is to conduct
additional analysis on an “A” Sample or “B” Sample after an analytical result for that Sample
has been reported (for example: additional Sample analysis to detect EPO, or GC/C/IRMS
analysis, or analysis in connection with the Athlete Biological Passport or additional analysis
on a stored Sample) it may do so after receiving approval from the Testing Authority or Results
Management Authority (if different) or WADA. However, after an Athlete has been charged
with a Code Article 2.1 anti-doping rule violation based on the presence of a Prohibited
Substance, Metabolite(s) of a Prohibited Substance, or Marker(s) of the Use of a Prohibited
Substance or Prohibited Method in a Sample, then Further Analysis on that Sample may only
be performed with the consent of the Athlete or approval from a hearing body (see Code
Article 6.5). Further Analysis may be performed by the same Laboratory that did the original
Analytical Testing, or by a different Laboratory or other WADA-approved Laboratory, at the
direction of the Testing Authority or Results Management Authority (if different) or WADA. Any
other Anti-Doping Organization that wishes to conduct Further Analysis on a stored Sample
may do so with the permission of the Testing Authority or Results Management Authority (if
different) or WADA and shall be responsible for any follow-up Results Management. Any
Sample storage or Further Analysis initiated by WADA or another Anti-Doping Organization
shall be at WADA’s or that Anti-Doping Organization’s expense.]

Laboratory: A WADA-accredited Laboratory applying Test Methods and processes to provide

evidentiary data for the detection and/or identification of Prohibited Substances or Prohibited
Methods on the Prohibited List, and if applicable, quantification of a Threshold Substance in
Samples of urine and other biological matrices in the context of Doping Control activities.

Major Event: A series of individual international Competitions conducted together under an

international multi-sport organization functioning as a ruling body (e.g., the Olympic Games,
Pan American Games) and for which a significant increase of resources and capacity may be
required to conduct Doping Control for the Event.

Passport: A collation of all relevant data unique to an individual Athlete that may include
longitudinal profiles of Markers, heterogeneous factors unique to that particular Athlete and
other relevant information that may help in the evaluation of Markers.

Risk Assessment: The assessment of risk of doping in a sport or sports discipline conducted
by an Anti-Doping Organization in accordance with Article 4.2 of the International Standard
for Testing and Investigations.

Sample Collection Authority: The organization that is responsible for the collection of
Samples in compliance with the requirements of the International Standard for Testing and
Investigations, whether (1) the Testing Authority itself; or (2) a Delegated Third Party to whom
the authority to conduct Testing has been granted or sub-contracted. The Testing Authority
always remains ultimately responsible under the Code for compliance with the requirements
of the International Standard for Testing and Investigations relating to collection of Samples.

TDSSA - Version 6.0, dated 11 November 2020 Page 17 of 25

 WADA Technical Document for Sport Specific Analysis

Document Number TDSSA Version Number: 6.0

Written By: TDSSA Expert Group Approved By: WADA Executive Committee
Approval Date: 11 November 2020 Effective Date: 1 January 2021

Sample Collection Session: All of the sequential activities that directly involve the Athlete
from the point that initial contact is made until the Athlete leaves the Doping Control Station
after having provided their Sample(s).

Technical Document for Sport Specific Analysis (TDSSA): The Technical Document
which establishes minimum levels of analysis that Anti-Doping Organizations must apply to
sports and sport disciplines for certain Prohibited Substances and/or Prohibited Methods,
which are most likely to be abused in particular sports and sport disciplines.

Test(s): Any combination of Sample(s) collected (and analyzed) from a single Athlete in a
single Sample Collection Session.

Test Distribution Plan: A document written by an Anti-Doping Organization that plans

Testing on Athletes, in accordance with the requirements of Article 4 of the International
Standard for Testing and Investigations.

Testing Authority: The Anti-Doping Organization that authorizes Testing on Athletes it has
authority over. It may authorize a Delegated Third Party to conduct Testing pursuant to the
authority of and in accordance with the rules of the Anti-Doping Organization. Such
authorization shall be documented. The Anti-Doping Organization authorizing Testing remains
the Testing Authority and ultimately responsible under the Code to ensure the Delegated Third
Party conducting the Testing does so in compliance with the requirements of the International
Standard for Testing and Investigations.

10.3. Defined terms specific to the TDSSA

Minimum Level of Analysis (MLA): The number of analyses for the Prohibited Substances
and/or Prohibited Methods within the scope of the TDSSA required to be performed by an
ADO for each sport or discipline, expressed as a percentage of the total eligible Tests in their
TDP.

Physiological Risk Assessment: Analysis of the physiological demands of a sport or

discipline against the potential performance enhancing benefit of Prohibited Substances
and/or Prohibited Methods on the TDSSA.

TDSSA - Version 6.0, dated 11 November 2020 Page 18 of 25

Appendix 1

Minimum Levels of Analysis for Sports and Disciplines of Olympic and IOC-Recognized International
Federations, and members of the Alliance of Independent Recognized Members of Sport

SPORT DISCIPLINE EPOs % GH %5 GHRFs %

Aikido Aikido 5 5 5
Air Sports All 0 0 0
American Football American Football 5 10 10
Aquatics Diving 0 5 5
Aquatics Swimming Sprint 100m or less 10 10 10
Swimming Long Distance 800m or
Aquatics greater 30 5 5
Aquatics Swimming Middle Distance 200-400m 15 5 5
Aquatics Open Water 30 5 5
Aquatics Artistic Swimming 10 5 5
Aquatics Water Polo 10 10 10
Archery All 0 0 0
Arm Wrestling Arm Wrestling 5 15 15
Athletics Combined Events 15 15 15
Athletics Jumps 10 15 15
Athletics Long Distance 3000m or greater 60 5 5
Athletics Middle Distance 800-1500m 30 10 10
Athletics Sprint 400m or less 10 15 15
Athletics Throws 5 15 15
Automobile Sports All 5 0 0
Badminton Badminton 10 10 10
Bandy Bandy 5 10 10
Baseball Baseball 5 10 10
Basketball Basketball 10 10 10
Basketball 3 on 3 10 10 10
Basque Pelota Basque Pelota 5 5 5
Biathlon Biathlon 60 10 10
Billiards Sports All 0 0 0
Bobsleigh Bobsleigh 5 10 10
Bobsleigh Skeleton 0 10 10
Bodybuilding Bodybuilding 5 30 30
Bodybuilding Fitness 10 30 30

5
The mandatory implementation of the GH MLAs for all sports/disciplines is postponed until the endocrine module of the ABP is ready for
implementation.

TDSSA - Version 6.0, dated 11 November 2020 Page 19 of 25

 SPORT DISCIPLINE EPOs% GH % GHRFs %
Boules Sports All 0 0 0
Bowling All 0 0 0
Boxing Boxing 15 10 10
Bridge Bridge 0 0 0
Canoe/Kayak Sprint 200m 10 10 10
Canoe/Kayak Canoe Slalom 15 10 10
Canoe/Kayak Canoe Polo 5 10 10
Canoe/Kayak Middle Distance 500m 15 10 10
Canoe/Kayak Dragon Boat 10 5 5
Canoe/Kayak Freestyle 5 10 10
Canoe/Kayak Long Distance 1000m 30 5 5
Canoe/Kayak Marathon 30 5 5
Canoe/Kayak Ocean Racing 15 5 5
Canoe/Kayak Wildwater 5 10 10
Casting Casting 0 0 0
Cheer Cheer 5 5 5
Chess Chess 0 0 0
Cricket All 5 10 10
Curling Curling 0 0 0
Cycling Artistic 5 5 5
Cycling BMX 5 10 10
Cycling Cycle-Ball 5 5 5
Cycling Cyclo-Cross 30 10 10
Cycling Mountain Bike - Down Hill 10 10 10
Cycling Mountain Bike - Cross Country 30 10 10
Cycling Road 60 10 10
Cycling Track Endurance 30 10 10
Cycling Track Sprint 5 10 10
Cycling Trials 5 5 5
Dance Sport All 5 5 5
Darts Darts 0 0 0
Dragon Boat Dragon Boat 10 5 5
Draughts Draughts 0 0 0
Equestrian Dressage 0 0 0
Equestrian Driving 0 0 0
Equestrian Eventing 5 5 5
Equestrian Endurance 5 5 5
Equestrian Jumping 5 5 5
Equestrian Reining 0 0 0

TDSSA - Version 6.0, dated 11 November 2020 Page 20 of 25

 SPORT DISCIPLINE EPOs % GH % GHRFs %
Equestrian Vaulting 5 5 5
Fencing Epee 5 5 5
Fencing Foil 5 5 5
Fencing Sabre 5 5 5
Field Hockey Field Hockey 10 10 10
Field Hockey Indoor 5 5 5
Fistball Fistball 5 5 5
Floorball Floorball 5 5 5
Flying Disc Ultimate 5 5 5
Football Beach Football 5 5 5
Football Football 10 10 10
Football Futsal 5 5 5
Go Go 0 0 0
Golf Golf 5 5 5
Gymnastics Artistic 10 10 10
Gymnastics Acrobatic 5 10 10
Gymnastics Rhythmic 5 5 5
Gymnastics Aerobic 10 5 5
Gymnastics Trampoline 5 5 5
Gymnastics Tumbling 5 5 5
Handball Beach 5 5 5
Handball Indoor 10 10 10
Ice Hockey Ice Hockey 5 10 10
Icestocksport Icestocksport Target 0 0 0
Icestocksport Icestocksport Distance 0 5 5
Ju-Jitsu All 10 10 10
Judo Judo 10 10 10
Karate Karate 10 10 10
Kendo Kendo 5 5 5
Kickboxing All 15 10 10
Korfball Korfball 10 5 5
Lacrosse Lacrosse 10 10 10
LifeSaving LifeSaving 10 5 5
Luge Luge 0 10 10
Minigolf Minigolf 0 0 0
Modern Pentathlon Modern Pentathlon 5 5 5
Motorcycle Racing All 5 0 0
Mountaineering and
Climbing All 10 5 5

TDSSA - Version 6.0, dated 11 November 2020 Page 21 of 25

 SPORT DISCIPLINE EPOs % GH % GHRFs %
Muaythai Muaythai 15 10 10
Netball Netball 10 5 5
Orienteering All 15 5 5
Polo All 5 5 5
Powerboating Aquabike 5 5 5
Powerboating Circuit 0 0 0
Powerboating Offshore 0 0 0
Powerlifting All 5 30 30
Racquetball Racquetball 10 5 5
Roller Sports Alpine and Inline Downhill 10 10 10
Roller Sports Artistic 5 5 5
Roller Sports Hockey 5 10 10
Inline Speed Skating Sprint 1000m
15 10 10
Roller Sports or less
Inline Speed Skating Distance greater
Roller Sports 30 10 10
than 1000m
Roller Sports Roller Derby 5 5 5
Roller Sports Roller Freestyle 5 10 10
Roller Sports Skateboarding 5 10 10
Rowing Rowing 30 10 10
Rugby Union Fifteens 10 10 10
Rugby Union Sevens 10 10 10
Sailing All 5 5 5
Sambo Sambo 10 10 10
Savate All 10 10 10
Sepaktakraw All 0 0 0
Shooting All 0 0 0
Skating Figure Skating 10 10 10
Skating Short Track 15 10 10
Skating Speed Skating 1500m or less 15 10 10
Skating Speed Skating greater than 1500m 30 10 10
Skating Synchronized Skating 10 5 5
Skiing Alpine 15 10 10
Skiing Cross-Country 60 10 10
Skiing Nordic Combined 30 10 10
Skiing Freestyle 10 5 5
Skiing Ski Jumping 0 5 5
Skiing Snowboard 10 5 5
Ski Mountaineering Ski Mountaineering 30 5 5
Sleddog Sleddog 0 0 0

TDSSA - Version 6.0, dated 11 November 2020 Page 22 of 25

 SPORT DISCIPLINE EPOs % GH % GHRFs %
Soft Tennis Soft Tennis 5 5 5
Softball Softball 5 10 10
Sport Climbing Boulder 10 5 5
Sport Climbing Combined 10 5 5
Sport Climbing Lead 10 5 5
Sport Climbing Speed 10 10 10
Sport Fishing Sport Fishing 0 0 0
Squash Squash 10 5 5
Sumo Sumo 10 10 10
Surfing All 10 5 5
Table Tennis Table Tennis 5 5 5
Taekwondo Poomsae 5 5 5
Taekwondo Sparring 10 10 10
Tennis Tennis 10 5 5
Triathlon All 60 10 10
Tug of War Tug of War 5 10 10
Underwater Sports Apnoea (all subdisciplines) 15 5 5
Underwater Sports Aquathlon (Underwater Wrestling) 15 10 10
Underwater Sports Finswimming Open Water 30 5 5
Underwater Sports Finswimming Pool 15 5 5
Underwater Sports Free Diving 15 5 5
Underwater Sports UW Orienteering 15 5 5
Underwater Sports Spearfishing 15 5 5
Underwater Sports Sport Diving 15 5 5
Underwater Sports Target Shooting 0 0 0
Underwater Sports UW Hockey 5 5 5
Underwater Sports UW Rugby 5 5 5
Volleyball Beach 5 5 5
Volleyball Volleyball 5 5 5
Waterskiing Barefoot 5 5 5
Waterskiing Cable Wakeboard 5 5 5
Waterskiing Cableski 5 5 5
Waterskiing Racing Water Ski 5 5 5
Waterskiing Tournament 5 5 5
Waterskiing Wakeboard Boat 5 5 5
Weightlifting Weightlifting 5 30 30
Wrestling All 15 10 10
Wushu Sanda 10 10 10
Wushu Taolu 5 5 5

TDSSA - Version 6.0, dated 11 November 2020 Page 23 of 25

Appendix 2

Minimum Levels of Analysis for Sports and Disciplines of Athletes with an Impairment

IPC Sports

SPORT DISCIPLINE EPOs % GH % GHRFs %

Para‐Alpine Skiing Para‐Alpine Skiing 5 5 5

Wheelchair Racing - All Distances
Para‐Athletics All Classes 30 10 10
Para‐Athletics Jumping - All Classes 5 10 10
Para‐Athletics Running Sprints 400m or less - All Classes 5 10 10
Running Middle Distance 800m - 1500m
Para‐Athletics All Classes 15 10 10
Running Endurance - greater than 1500m
Para‐Athletics All Classes 30 5 5
Para‐Athletics Seated Throws - Classes: F31-F34/F51-F53 5 5 5
Para‐Athletics Seated Throws - Classes: F54-F57 5 10 10
Para‐Athletics Standing Throws - All Classes 5 10 10
Para‐Nordic Skiing All 30 10 10
Para‐DanceSport Para‐DanceSport 0 0 0
Para‐Ice Hockey Para‐Ice Hockey 5 5 5
Para‐Powerlifting Para‐Powerlifting 5 30 30
Para‐Snowboard Para‐Snowboard 5 5 5
Para‐Swimming Classes: S1/SB1/SM1-S3/SB3/SM3 5 5 5
Para‐Swimming Classes: S4/SB4/SM4-S9/SB8/SM9 15 5 5
Para‐Swimming Classes: S10/SB9/SM10-S14/SB14 30 10 10
Shooting Para Sport Shooting Para Sport 0 0 0

TDSSA - Version 6.0, dated 11 November 2020 Page 24 of 25

Appendix 2

Non-IPC Sports

SPORT DISCIPLINE EPOs % GH GHRFs

% %
Archery Para‐Archery 0 0 0
Arm Wrestling Para-Arm Wrestling 5 15 15
Badminton Para‐Badminton 5 5 5
Basketball Wheelchair Basketball 5 5 5
Bobsleigh Para‐Bobsleigh 5 5 5
Boccia Para‐Boccia 0 0 0
Canoe/Kayak Para‐Canoe Sprint 10 10 10
Curling Wheelchair Curling 0 0 0
Cycling Para-Cycling 30 5 5
Equestrian Para‐Equestrian 0 0 0
Fencing Wheelchair Fencing 5 5 5
Field Hockey Para‐Field Hockey 5 5 5
Football 5‐a‐side Para‐Football 5‐a‐side 5 5 5
Football 7‐a‐side Para‐Football 7-a‐side 5 5 5
Goalball Goalball 5 5 5
Handball Wheelchair Handball 5 5 5
Judo Para‐Judo 10 10 10
Rowing Para‐Rowing 30 10 10
Rugby Wheelchair Rugby 5 5 5
Sailing Para‐Sailing 0 0 0
ParaVolley Sitting Volleyball 5 5 5
ParaVolley Beach ParaVolley 5 5 5
Table Tennis Para‐Table Tennis 5 5 5
Taekwondo Para‐Taekwondo‐Kyorugi 10 10 10
Tennis Wheelchair Tennis 5 5 5
Triathlon Para‐Triathlon 30 10 10
Waterskiing Disabled 0 0 0

TDSSA - Version 6.0, dated 11 November 2020 Page 25 of 25